Primary Percutaneous Coronary Intervention with High-Bolus Dose Tirofiban: The FASTER (Favorite Approach to Safe and Effective Treatment for Early Reperfusion) Multicenter Registry
Objectives. To investigate the safety and clinical efficacy of tirofiban during primary percutaneous coronary interventions (pPCI). Background. Gp IIb/IIIa inhibitors (GPI) use during pPCI has declined over years, mainly for the increased hemorrhagic risk associated to their use and for the availabi...
| الحاوية / القاعدة: | Journal of Interventional Cardiology |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wiley
2022-01-01
|
| الوصول للمادة أونلاين: | http://dx.doi.org/10.1155/2022/9609970 |
